We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




New Quantitative Imaging Markers Could Improve Cancer Detection, Diagnosis and Treatment

By MedImaging International staff writers
Posted on 24 Mar 2022
Print article
Image: Researchers will use AI to develop new quantitative imaging markers for cancer (Photo courtesy of Unsplash)
Image: Researchers will use AI to develop new quantitative imaging markers for cancer (Photo courtesy of Unsplash)

Medical imaging is an essential tool to help doctors and scientists assess the size and scope of a tumor that will be effectively removed by surgery, as well as the rate at which tumors shrink in response to medical interventions such as chemotherapy or radiation therapy. Researchers are now investigating multiple avenues, including the development of quantitative imaging markers, to help improve medical imaging use in cancer detection, diagnosis and treatment.

Researchers at the Oklahoma Center of Medical Imaging for Translational Cancer Research (Norman, OK, USA) are developing quantitative imaging markers to provide an objective measure or index that can reduce subjectivity and improve consistency for medical image diagnosis using two primary types of research approaches. The first approach is to develop new investigative cutting-edge imaging modalities to expand ability of doctors to see or detect more detailed tumor internal structures such as using the advanced optical imaging modalities and technology. The second is to explore and extract more effective image features from the existing clinical imaging modalities - like CT, MRI and X-ray images - and then using artificial intelligence or machine learning models to develop new quantitative imaging markers to help reduce subjectivity and variability of cancer diagnosis and predicting cancer prognosis.

The center is beginning with four projects currently underway. In the first project, the researchers are using improved imaging modalities and quantitative markers to more clearly define the margin of a tumor to improve patient outcomes. The second project will focus on developing a 3D super-resolution optical microscope as a novel and unique method which enables researchers to better understand the intracellular pathways that nanoparticles take during transcytosis to treat tumors. The center will support the purchase of a 3D super-resolution optical microscope to allow researchers to better study nanomedicine, a branch of medicine that fuses nanotechnology and medicine for cancer treatment and prevention. The high-powered microscope will improve research in this area.

The third project aims to use artificial intelligence and machine learning with current CT imaging and pathology data to develop a model that can inform the establishment of imaging markers that can reduce subjectivity and variability of imaging results and improve patient treatment. The fourth project aims to use new investigative imaging methods, optical coherence tomography and full-field optical coherence tomography to test an exploratory cancer drug. Previous studies have shown that an anti-parasitic drug may have the potential to treat certain forms of cancer, including ovarian cancer, but more research is needed for scientists to better understand its effects.

“When some patients undergo cancer treatments, some will respond favorably while others do not. The tumor continues to grow, so if we can develop a quantitative imaging marker to predict a patient’s likelihood to respond to a certain kind of chemotherapy or treatment, we can help physicians explore an alternative approach that may be more effective,” said Bin Zheng, Ph.D., a professor and Oklahoma TSET Cancer Research Scholar in the Gallogly College of Engineering’s School of Electrical and Computer Engineering, is leading the center.

“We propose to develop a new approach to identify new quantitative image markers computed from three types of neuroimaging data using artificial intelligence, which enables us to more clearly define the margin of the tumor, predict the recovery of neurological deficits, and thus help improve surgical effect and survival of patients,” said Han Yuan, Ph.D., an associate professor in the Stephenson School of Biomedical Engineering at OU Norman, who is leading the project, “Neuroimaging Markers for Predicting Outcome of Brain Surgery.”

Related Links:
Oklahoma Center of Medical Imaging for Translational Cancer Research 

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Portable X-Ray Unit
AJEX240H
New
Ultrasound Table
Powered Ultrasound Table-Flat Top
Dose Calibration Electrometer
PC Electrometer

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.